FIELD: pharmacology.
SUBSTANCE: invention relates to a new 3-[3-(morpholine-4-yl)propyl]-2-[(2,2,3-trimethylcyclopent-3-ene-1-yl)methyl]-1,3-thiazolidine-4-one compound.
EFFECT: new compound with anti-ulcer and anti-inflammatory activity is obtained.
2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTION OF ULCERATION OF GASTRIC MUCOSA | 2020 |
|
RU2744455C1 |
5-ETHYL-2-AMINO-1,3,4-THIADIAZOLE DERIVATIVES WITH ANESTHETIC, ANTI-INFLAMMATORY, ANTI-ALLERGIC AND ANALGETIC ACTIVITY | 2016 |
|
RU2651572C2 |
13-ISOPROPYL-4,10-DIMETHYLDODECAHYDRO-13,16-EPOXYOXIRENO[2,3]NAPHTHO[2,1-d][1,2]DIOXYCIN-4-CARBOXYLIC ACID AGENT, EXHIBITING ANTI-INFLAMMATORY AND ANTIULCER ACTIVITY | 2011 |
|
RU2472787C1 |
PREPARATION, POSSESSING GASTROPROTECTIVE ACTIVITY | 2014 |
|
RU2536225C1 |
METHOD FOR PREVENTION OF ULTRA CASING ON GASTRIC MUCOSA | 2021 |
|
RU2759575C1 |
AGENT IN FORM OF 8-(METHOXYCARBONYL)-4b,8-DIMETHYL-3-(2-METHYLPROPANOYL)-TETRADECAHYDROPHENANTHRENE-1,2,10a-TRICARBOXYLIC ACID AND PREPARATION METHOD THEREOF | 2009 |
|
RU2426720C1 |
DEANOL ACEGLUMATE DEMONSTRATING ANTIULCEROGENIC, GASTROPROTECTIVE AND ENTEROPROTECTIVE ACTIVITY, COMBINATION POSSESSING ANTIULCEROGENIC, GASTROPROTECTIVE AND ENTEROPROTECTIVE ACTIVITY (VERSIONS), PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2435575C2 |
ANTI-ULCER AGENT | 2000 |
|
RU2187322C2 |
METHOD FOR PREVENTION OF GASTRIC MUCOSA ULCERATION | 2011 |
|
RU2481111C1 |
PHARMACOLOGICAL AGENT FOR THE TREATMENT OF GASTRIC ULCER | 2018 |
|
RU2688187C1 |
Authors
Dates
2018-02-05—Published
2017-04-03—Filed